Back to top
Eltrombopag Olamine Tablets 50 mg
Eltrombopag Olamine Tablets 50 mg
Eltrombopag Olamine Tablets 50 mg
Eltrombopag Olamine Tablets 50 mg
Eltrombopag Olamine Tablets 50 mg
Eltrombopag Olamine Tablets 50 mg
Eltrombopag Olamine Tablets 50 mg
Eltrombopag Olamine Tablets 50 mg
Eltrombopag Olamine Tablets 50 mg
Eltrombopag Olamine Tablets 50 mg
Eltrombopag Olamine Tablets 50 mg
Eltrombopag Olamine Tablets 50 mg

Eltrombopag Olamine Tablets 50 mg

Price 1140.0 INR/ Strip

MOQ : 1 Piece

Eltrombopag Olamine Tablets 50 mg Specification

  • Pacakaging (Quantity Per Box)
  • 2X1X7
  • Indication
  • Chronic Immune Thrombocytopenia (ITP)
  • Origin of Medicine
  • INDIA
  • Dosage Form
  • Oral Tablet
  • Salt Composition
  • Eltrombopag Olamine Tablets 50 mg
  • Drug Type
  • Organic Medicine
  • Ingredients
  • LTROLAMINE 50 is a prescription medicine containing Eltrombopag Olamine Tablets 50 mg, a clinically proven thrombopoietin receptor agonist used to manage low platelet count (thrombocytopenia). Platelets play a vital role in blood clotting, and a deficiency can increase the risk of bleeding and bruising. LTROLAMINE 50 works by stimulating the bone marrow to produce more platelets, helping restore platelet levels to a safer range. This medicine is widely prescribed in conditions such as chronic immune thrombocytopenia (ITP), thrombocytopenia associated with chronic hepatitis C, and severe aplastic anemia when other treatments have not shown adequate response. LTROLAMINE 50 offers a targeted approach to platelet management under strict medical supervision. Uses LTROLAMINE 50 is primarily used for the treatment and management of platelet disorders, including: Chronic Immune Thrombocytopenia (ITP) in adults and children who do not respond adequately to corticosteroids, immunoglobulins, or splenectomy Thrombocytopenia in patients with chronic hepatitis C to allow initiation and maintenance of antiviral therapy Severe aplastic anemia in patients who are refractory to immunosuppressive therapy By improving platelet counts, LTROLAMINE 50 helps reduce the risk of bleeding complications and improves overall clinical outcomes. Benefits LTROLAMINE 50 offers several important therapeutic benefits: Effectively increases platelet production by stimulating thrombopoietin receptors Helps reduce spontaneous bleeding and bruising associated with low platelet counts Supports continuity of antiviral therapy in hepatitis C patients Provides an oral treatment option, avoiding frequent platelet transfusions Useful in long-term management of chronic platelet disorders under medical guidance With regular monitoring, LTROLAMINE 50 helps patients achieve stable platelet levels and better quality of life. Dosage The dosage of LTROLAMINE 50 should be strictly followed as prescribed by a healthcare professional. The dose may vary depending on the patient s condition, platelet count, age, and response to treatment. Usually taken once daily Should be taken on an empty stomach, at least 1 hour before or 2 hours after meals Avoid dairy products, calcium, iron, magnesium, aluminum-containing antacids, or mineral supplements within 4 hours of taking the tablet Regular blood tests are essential to monitor platelet levels and adjust the dose accordingly. Do not stop or change the dose without consulting your doctor. Side Effects Like all medicines, LTROLAMINE 50 may cause side effects, although not everyone experiences them. Commonly reported side effects include: Headache Nausea or vomiting Diarrhea Fatigue Muscle or joint pain Some patients may experience elevated liver enzymes, which is why liver function monitoring is important. Rare but serious side effects may include blood clot formation if platelet levels rise excessively. Seek immediate medical attention if unusual symptoms occur. Precautions and Warning Before using LTROLAMINE 50, inform your doctor if you have liver disease, history of blood clots, or any other chronic medical condition. Important precautions include: Regular monitoring of platelet count and liver function tests Use with caution in patients with hepatic impairment Not recommended during pregnancy unless clearly advised by a physician Breastfeeding mothers should consult a doctor before use Avoid self-medication and long-term use without medical supervision LTROLAMINE 50 is a prescription-only medicine and should be used only under expert medical guidance. Conclusion LTROLAMINE 50, containing Eltrombopag Olamine Tablets 50 mg, is a reliable and effective treatment option for managing thrombocytopenia in conditions such as chronic ITP, hepatitis C associated low platelet count, and severe aplastic anemia. By stimulating platelet production at the source, it helps reduce bleeding risks and supports long-term disease management. When used responsibly with regular medical monitoring, LTROLAMINE 50 plays a crucial role in improving patient safety, treatment continuity, and overall quality of life. Always follow your doctor s advice to achieve the best therapeutic outcomes.
  • Physical Form
  • Tablets
  • Function
  • Other
  • Recommended For
  • Patients with low platelet count (Thrombocytopenia)
  • Dosage
  • 50 mg once daily (or as directed by physician)
  • Dosage Guidelines
  • Take on an empty stomach
  • Suitable For
  • Adults
  • Quantity
  • 10 Strip
  • Storage Instructions
  • Store in a cool and dry place
 

Eltrombopag Olamine Tablets 50 mg Trade Information

  • Minimum Order Quantity
  • 1 Piece
  • Delivery Time
  • 4 Days
 

About Eltrombopag Olamine Tablets 50 mg

LTROLAMINE 50 is a prescription medicine containing Eltrombopag Olamine Tablets 50 mg, a clinically proven thrombopoietin receptor agonist used to manage low platelet count (thrombocytopenia). Platelets play a vital role in blood clotting, and a deficiency can increase the risk of bleeding and bruising. LTROLAMINE 50 works by stimulating the bone marrow to produce more platelets, helping restore platelet levels to a safer range.

This medicine is widely prescribed in conditions such as chronic immune thrombocytopenia (ITP), thrombocytopenia associated with chronic hepatitis C, and severe aplastic anemia when other treatments have not shown adequate response. LTROLAMINE 50 offers a targeted approach to platelet management under strict medical supervision.

Uses

LTROLAMINE 50 is primarily used for the treatment and management of platelet disorders, including:

  • Chronic Immune Thrombocytopenia (ITP) in adults and children who do not respond adequately to corticosteroids, immunoglobulins, or splenectomy

  • Thrombocytopenia in patients with chronic hepatitis C to allow initiation and maintenance of antiviral therapy

  • Severe aplastic anemia in patients who are refractory to immunosuppressive therapy

By improving platelet counts, LTROLAMINE 50 helps reduce the risk of bleeding complications and improves overall clinical outcomes.

Benefits

LTROLAMINE 50 offers several important therapeutic benefits:

  • Effectively increases platelet production by stimulating thrombopoietin receptors

  • Helps reduce spontaneous bleeding and bruising associated with low platelet counts

  • Supports continuity of antiviral therapy in hepatitis C patients

  • Provides an oral treatment option, avoiding frequent platelet transfusions

  • Useful in long-term management of chronic platelet disorders under medical guidance

With regular monitoring, LTROLAMINE 50 helps patients achieve stable platelet levels and better quality of life.

Dosage

The dosage of LTROLAMINE 50 should be strictly followed as prescribed by a healthcare professional. The dose may vary depending on the patients condition, platelet count, age, and response to treatment.

  • Usually taken once daily

  • Should be taken on an empty stomach, at least 1 hour before or 2 hours after meals

  • Avoid dairy products, calcium, iron, magnesium, aluminum-containing antacids, or mineral supplements within 4 hours of taking the tablet

Regular blood tests are essential to monitor platelet levels and adjust the dose accordingly. Do not stop or change the dose without consulting your doctor.

Side Effects

Like all medicines, LTROLAMINE 50 may cause side effects, although not everyone experiences them. Commonly reported side effects include:

  • Headache

  • Nausea or vomiting

  • Diarrhea

  • Fatigue

  • Muscle or joint pain

Some patients may experience elevated liver enzymes, which is why liver function monitoring is important. Rare but serious side effects may include blood clot formation if platelet levels rise excessively. Seek immediate medical attention if unusual symptoms occur.

Precautions and Warning

Before using LTROLAMINE 50, inform your doctor if you have liver disease, history of blood clots, or any other chronic medical condition. Important precautions include:

  • Regular monitoring of platelet count and liver function tests

  • Use with caution in patients with hepatic impairment

  • Not recommended during pregnancy unless clearly advised by a physician

  • Breastfeeding mothers should consult a doctor before use

  • Avoid self-medication and long-term use without medical supervision

LTROLAMINE 50 is a prescription-only medicine and should be used only under expert medical guidance.

Conclusion

LTROLAMINE 50, containing Eltrombopag Olamine Tablets 50 mg, is a reliable and effective treatment option for managing thrombocytopenia in conditions such as chronic ITP, hepatitis Cassociated low platelet count, and severe aplastic anemia. By stimulating platelet production at the source, it helps reduce bleeding risks and supports long-term disease management.

When used responsibly with regular medical monitoring, LTROLAMINE 50 plays a crucial role in improving patient safety, treatment continuity, and overall quality of life. Always follow your doctors advice to achieve the best therapeutic outcomes.




Mechanism of Action: How LTROLAMINE 50 Works

LTROLAMINE 50 contains eltrombopag olamine, a thrombopoietin receptor agonist. It acts on the bone marrow, prompting it to produce more platelets, thereby addressing platelet deficits. By increasing these crucial blood cells, the medication helps minimize bleeding risks and supports normal blood clotting functions.


Dosage and Administration Guidelines

For optimal outcomes, LTROLAMINE 50 should be taken as a 50 mg tablet once daily, ideally on an empty stomach-at least one hour before or two hours after meals. Avoid taking dairy products or mineral supplements close to the dosage time. Adherence to your physician's instructions and regular blood monitoring is essential.


Therapeutic Benefits and Clinical Applications

This medicine is widely utilized in the management of chronic ITP, thrombocytopenia due to hepatitis C, and severe aplastic anemia. By reducing the need for frequent platelet transfusions, LTROLAMINE 50 offers a less invasive and more sustainable treatment option, supporting better quality of life for affected patients.

FAQ's of Eltrombopag Olamine Tablets 50 mg:


Q: How should I take LTROLAMINE 50 Eltrombopag Olamine Tablets?

A: Take one tablet of LTROLAMINE 50 mg once daily, strictly following your doctor's prescription. It should be swallowed whole with water on an empty stomach, at least one hour before or two hours after meals.

Q: What is the main benefit of using LTROLAMINE 50 for patients with low platelet count?

A: LTROLAMINE 50 helps increase platelet production by stimulating bone marrow activity, thereby reducing the chances of bleeding and bruising associated with low platelet counts in conditions like ITP and hepatitis C.

Q: When can I expect to notice improvements in my platelet levels?

A: Improvements vary by individual, but platelet levels are typically monitored weekly at the beginning of therapy. Your physician will guide you based on your specific response and periodic blood test results.

Q: Are there any medications or foods I should avoid while taking LTROLAMINE 50?

A: Yes, avoid consuming dairy products, calcium, iron, magnesium, aluminum-containing antacids, or mineral supplements within four hours of taking the tablet to prevent interference with absorption.

Q: What precautions should I take while using this medication?

A: Regular blood tests are required to monitor your platelet count and liver function. Inform your doctor if you have liver conditions or a history of blood clots. Do not self-medicate or discontinue without medical advice.

Q: Who should not use LTROLAMINE 50 Eltrombopag Olamine Tablets?

A: Pregnant or breastfeeding women should consult their physician before use. It is not recommended without medical supervision, especially in patients with significant liver impairment or those at risk of blood clots.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in General Range Category

Sultamicillin (375mg)

Sultamicillin (375mg)

Price 434 INR / Strip

Minimum Order Quantity : 1 Strip

Physical Form : Tablets

Origin of Medicine : India

Storage Instructions : Cool and dry place

Salt Composition : Sultamicillin (375mg)

Calcium Aspartate 1120mg, Magnesium Hydroxide 180mg, Vitamin D3 10mcg,

Calcium Aspartate 1120mg, Magnesium Hydroxide 180mg, Vitamin D3 10mcg,

Price 211 INR / Strip

Minimum Order Quantity : 1 Strip

Physical Form : Tablets

Origin of Medicine : India

Storage Instructions : Cool and dry place

Salt Composition : Calcium Aspartate 1120mg, Magnesium Hydroxide 180mg, Vitamin D3 10mcg,

Faropenem Sodium 200mg

Faropenem Sodium 200mg

Price 489 INR / Box

Minimum Order Quantity : 1 Box

Physical Form : Tablets

Origin of Medicine : India

Storage Instructions : Cool and dry place

Salt Composition : Faropenem Sodium 200mg

Providone Iodine 5% Higher Strength

Providone Iodine 5% Higher Strength

Price 120 INR / Bottle

Minimum Order Quantity : 1 Bottle

Physical Form : Liquid

Origin of Medicine : India

Storage Instructions : Cool and dry place

Salt Composition : Providone Iodine 5% Higher Strength